Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 27155012)

Published in Proc Natl Acad Sci U S A on May 06, 2016

Authors

Jasmin Corso1, Kuan-Ting Pan1, Roland Walter2, Carmen Doebele2, Sebastian Mohr2, Hanibal Bohnenberger3, Philipp Ströbel3, Christof Lenz4, Mikolaj Slabicki5, Jennifer Hüllein5, Federico Comoglio6, Michael A Rieger7, Thorsten Zenz8, Jürgen Wienands9, Michael Engelke9, Hubert Serve7, Henning Urlaub10, Thomas Oellerich11

Author Affiliations

1: Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, 37077 Goettingen, Germany;
2: Hematology/Oncology, Department of Medicine, Johann Wolfgang Goethe University, 60590 Frankfurt, Germany;
3: Institute of Pathology, University Medical Center Göttingen, 37075 Goettingen, Germany;
4: Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, 37077 Goettingen, Germany; Bioanalytics, Institute for Clinical Chemistry, University Medical Center Göttingen, 37075 Goettingen, Germany;
5: Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases, 69120 Heidelberg, Germany; German Cancer Research Center, 69120 Heidelberg, Germany;
6: Department of Haematology, Cambridge Institute of Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
7: Hematology/Oncology, Department of Medicine, Johann Wolfgang Goethe University, 60590 Frankfurt, Germany; German Cancer Consortium/German Cancer Research Center, 69120 Heidelberg, Germany;
8: Molecular Therapy in Hematology and Oncology, Department of Translational Oncology, National Center for Tumor Diseases, 69120 Heidelberg, Germany; German Cancer Research Center, 69120 Heidelberg, Germany; Department of Medicine V, Heidelberg University Medical Center, 69120 Heidelberg, Germany; European Molecular Biology Laboratory, 69117 Heidelberg, Germany;
9: Institute for Cellular and Molecular Immunology, University Medical Center Göttingen, 37073 Goettingen, Germany.
10: Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, 37077 Goettingen, Germany; Bioanalytics, Institute for Clinical Chemistry, University Medical Center Göttingen, 37075 Goettingen, Germany; henning.urlaub@mpibpc.mpg.de Thomas.Oellerich@kgu.de.
11: Hematology/Oncology, Department of Medicine, Johann Wolfgang Goethe University, 60590 Frankfurt, Germany; Department of Haematology, Cambridge Institute of Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom; German Cancer Consortium/German Cancer Research Center, 69120 Heidelberg, Germany; henning.urlaub@mpibpc.mpg.de Thomas.Oellerich@kgu.de.

Articles cited by this

Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol (2008) 38.00

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med (2013) 16.33

Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res (2011) 14.82

ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol (2014) 13.40

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature (2010) 8.78

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell (1997) 7.18

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science (2008) 6.52

A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc (2006) 5.21

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33

Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell (2004) 4.31

ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol (2006) 2.63

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med (2015) 2.42

Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature (2012) 2.36

B cell signaling and fate decision. Annu Rev Immunol (2010) 2.33

Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov (2013) 2.31

Aiolos regulates B cell activation and maturation to effector state. Immunity (1998) 2.24

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07

Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nat Genet (2003) 1.96

The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol (2008) 1.79

An optimized microRNA backbone for effective single-copy RNAi. Cell Rep (2013) 1.78

Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc Natl Acad Sci U S A (1996) 1.60

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration. Leukemia (2012) 1.49

High-throughput SNP-based authentication of human cell lines. Int J Cancer (2012) 1.46

Stage-specific control of early B cell development by the transcription factor Ikaros. Nat Immunol (2014) 1.42

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros. Proc Natl Acad Sci U S A (2012) 1.30

The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol (2011) 1.27

Leupaxin is a novel LIM domain protein that forms a complex with PYK2. J Biol Chem (1998) 1.19

The cytoskeleton coordinates the early events of B-cell activation. Cold Spring Harb Perspect Biol (2011) 1.17

A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase. J Exp Med (2000) 1.16

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis. J Pharmacol Exp Ther (2011) 1.09

Ligand-independent tonic signaling in B-cell receptor function. Curr Opin Immunol (2004) 1.01

Regulation of BCR signaling. Mol Immunol (2010) 1.01

Deep proteomics of mouse skeletal muscle enables quantitation of protein isoforms, metabolic pathways, and transcription factors. Mol Cell Proteomics (2015) 0.99

Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cells. Nat Immunol (2013) 0.99

Nfkb 1 is dispensable for Myc-induced lymphomagenesis. Oncogene (2005) 0.97

Leupaxin negatively regulates B cell receptor signaling. J Biol Chem (2007) 0.95

ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst (2016) 0.93

β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. Blood (2013) 0.92

Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation. Mol Syst Biol (2015) 0.92

Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens. Proc Natl Acad Sci U S A (2015) 0.91

The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer. Cell Biosci (2015) 0.89

Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing. Leukemia (2013) 0.88

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood (2014) 0.85

SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins. Mol Cell Proteomics (2009) 0.85

The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia. Blood (2008) 0.84

Abl2/Abl-related gene stabilizes actin filaments, stimulates actin branching by actin-related protein 2/3 complex, and promotes actin filament severing by cofilin. J Biol Chem (2014) 0.84

PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks. J Proteome Res (2015) 0.80

Macromolecular assembly of the adaptor SLP-65 at intracellular vesicles in resting B cells. Sci Signal (2014) 0.77